CATimelineAuthorisation object
General timespan (max nr days)
60 (IMP Type A+B) or 30 (IMP Type C)
Mode of approval (General)
Explicit (IMP Type A) or Tacit (IMP Type B+C)
ATMP/GMO trials (max nr days)
90
Mode of approval (ATMP/GMO trials)
Explicit
External expert advice required (max nr days)
180
Additional Information
Types of IMP obtained by biotechnology or containing substances of human or animal origin:
Type A: IMP is NOT authorised in the Czech Republic or in other EU Member States.
Type B: IMP is authorised in the Czech Republic or in other EU Member States, but not used in accordance with the terms of marketing authorization
Type C: IMP is authorised in the Czech Republic and used in accordance with the terms of marketing authorisation
![This project (ECRIN Integrating Activity/ECRIN-IA) has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 284395 This project (ECRIN Integrating Activity/ECRIN-IA) has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 284395](/media/cms_page_media/2015/11/10/flag_yellow_low_100.jpg)